Hemay107

N/A

Report date: 2023/01/14 21:03:17
NME

Base Information

Drug NameHemay107
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPancreatic NeoplasmsLiver NeoplasmsStomach Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTianjin Hemay Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Hemay Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic NeoplasmsLiver NeoplasmsStomach Neoplasms +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A